To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM

NCT05814406 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: JW0201
DRUG: Placebo

Sponsor

JW Pharmaceutical